Emami

₹391.30As of Sun 8 Nov 2026, 12:00 UTC

NSE:EMAMILTDConsumer Staples

Country India

PE (Fwd) 20.43

TSR 10Y CAGR (2.76%)

Div yield 2.56%

ROE —

Household & Personal Products

Beta (5Y) 0.15

PE TTM 22.03

TSR TTM (25.33%)

Mkt cap ₹179.3B

ROIC —

SE Grade™

Value

Quality

Moat

—

1Y Price

Reference

₹420

7.32%

(47.65%)

Price above Reference Value

TTM

FYE 31 Mar INR

FY2017

FY2018

FY2019

FY2020

FY2021

FY2022

FY2023

FY2024

FY2025

FY2026

FY2027E

Trend

10Y

Peers

37.80

Revenue₹B

—

31.87

34.06

35.78

38.09

37.80

39.56

4.35%

(0.78)

Revenue growth%

—

6.86

5.06

6.46

(0.78)

4.68

5.76

—

68.86

Gross margin%

—

65.37

63.59

66.46

67.64

68.86

68.81

66.46

20.99

Operating margin%

—

19.55

18.76

21.53

22.41

20.99

20.96

20.99

20.51

Net margin%

—

26.32

18.78

20.22

21.17

20.51

20.28

20.51

22.03

P/E ratio (avg)x

—

28.15

30.01

29.34

36.30

30.25

21.29

30.01

21.53

EV/EBITx

—

37.91

30.05

27.56

34.30

29.57

20.59

30.05

—

FCF yield (avg)%

—

FCF margin%

—

FCF / Net incomex

—

ROIC%

—

Return on equity%

—

Return on assets%

—

17.76

EPS₹

—

18.89

14.50

16.55

18.48

17.76

18.38

(1.52%)

—

(3.87)

EPS growth%

—

(23.23)

14.13

11.66

(3.87)

3.48

3.89

—

Bookvalue per sh₹

—

FCF per share₹

—

10.00

Dividend per sh₹

—

8.00

10.00

10.53

5.74%

—

2.56

Div yield (avg)%

—

1.50

1.84

1.65

1.19

1.86

2.69

1.65

56.31

Payout ratio%

—

42.37

55.18

48.35

43.30

56.31

57.32

48.35

436.5

Shares (diluted)M

—

444.3

441.1

437.3

436.5

◌436.5

(0.44%)

—

Buyback yield%

—

0.70

0.88

0.17

—

◌—

0.44

—

D/E ratiox

—

170.8

Enterprise value₹B

—

236.2

191.9

212.3

292.8

234.5

170.8

(0.18%)

—

LT debt₹M

—

Peers (US$1.800B)

Cap (US$)

Gillette India Limited

2.569B

36.24x

Procter & Gamble…

2.396B

28.47x

Honasa Consumer Limited

1.614B

53.61x

Yunnan Botanee Bio…

1.838B

22.77x

Capital

TTM

10Y

Leveragex

—

EBIT/Intx

71.27

86.42

Own earn%

—

Sh yield%

2.56

2.19

Owners

Insiders/Inst%

7.06

41.70

Short interest%

—

SBC / revenue%

—

Record

10Y

Profitable years

5/5

Revenue growth years

3/4

EPS growth years

2/4

Dividend streakyrs

Op margin range%

19–22

$1 testx

—

Incr. ROIC%

—

Emami Limited, together with its subsidiaries, manufactures and markets personal and healthcare products in India and internationally.

Growth vs revenue

Latest

Trend

4Y CAGR

Rel growth

Revenue

₹37.80B

4.35%

1.00×

Cost of revenue

₹11.77B

1.61%

0.90×

Operating expenses

₹18.09B

5.50%

1.04×

Revenue by region

No breakdown available

Reinvestment returns

n/m

Trend

Reinvestment rate

n/m

Return on capital

n/m

Spread over hurdle

n/m